Skip to main content

1 Result(s)

within In-Kyu Kim Remove this filter Epidemiology Remove this filter

and

  1. No Access

    Article

    Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine

    Thymic epithelial tumours (TETs) are rare tumours comprised of thymomas and thymic carcinoma. Novel therapies are needed, especially in thymic carcinoma where the 5-year survival rate hovers at 30%. Mesothelin...

    Vincent Chen, Shigeki Umemura, Yumin Han, Renuka Raman… in British Journal of Cancer (2022)